Literature DB >> 35997934

Regulation of Conformational Changes in C-reactive Protein Alters its Bioactivity.

Naeem Ullah1, Yi Wu2,3.   

Abstract

The acute phase C-reactive protein (CRP) is mainly synthesized and secreted by the liver in a cytokine-mediated response to infection or inflammation and circulates as a pentamer (pCRP) in plasma. Recent studies indicate that CRP is not only a marker but is directly involved in inflammation. CRP has a vital role in host defense and inflammation, metabolic function and scavenging through its ability for calcium depended binding to exogenous and endogenous molecules having phosphocholine followed by activation of the classical complement pathway. Accumulating evidence indicates that pCRP dissociates into monomeric CRP (mCRP) and most proinflammatory actions of CRP are only expressed following dissociation of its native pentameric assembly into mCRP. The dissociation of CRP into mCRP altogether promotes the ligand-binding capability. mCRP emerges to be the main conformation of CRP that participates in the regulation of local inflammation, however, little is identified concerning what triggers the significantly enhanced actions of mCRP and their binding to diverse ligands. The separation of mCRP from pCRP may be a direct relationship between CRP and inflammation. Here we review the current literature on CRP dissociation and its interaction with different ligands. The possibility to avoid the generation of the proinflammatory potential of mCRP has driven therapeutic approaches by targeting the dissociation mechanism of pCRP or inhibition of mCRP itself during inflammation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  C-reactive protein; Conformational changes; Inflammation; Ligands binding; Monomeric CRP

Mesh:

Substances:

Year:  2022        PMID: 35997934     DOI: 10.1007/s12013-022-01089-x

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.989


  100 in total

1.  Cell membranes and liposomes dissociate C-reactive protein (CRP) to form a new, biologically active structural intermediate: mCRP(m).

Authors:  Shang-Rong Ji; Yi Wu; Li Zhu; Lawrence A Potempa; Fen-Ling Sheng; Wei Lu; Jing Zhao
Journal:  FASEB J       Date:  2006-11-20       Impact factor: 5.191

Review 2.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

3.  Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy.

Authors:  Jan R Thiele; Jonathon Habersberger; David Braig; Yvonne Schmidt; Kurt Goerendt; Valentin Maurer; Holger Bannasch; Amelie Scheichl; Kevin J Woollard; Ernst von Dobschütz; Frank Kolodgie; Renu Virmani; G Bjoern Stark; Karlheinz Peter; Steffen U Eisenhardt
Journal:  Circulation       Date:  2014-04-28       Impact factor: 29.690

Review 4.  Function of C-reactive protein.

Authors:  T W Du Clos
Journal:  Ann Med       Date:  2000-05       Impact factor: 4.709

5.  C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.

Authors:  A D Pradhan; J E Manson; N Rifai; J E Buring; P M Ridker
Journal:  JAMA       Date:  2001-07-18       Impact factor: 56.272

6.  Three dimensional structure of human C-reactive protein.

Authors:  A K Shrive; G M Cheetham; D Holden; D A Myles; W G Turnell; J E Volanakis; M B Pepys; A C Bloomer; T J Greenhough
Journal:  Nat Struct Biol       Date:  1996-04

7.  The physiological structure of human C-reactive protein and its complex with phosphocholine.

Authors:  D Thompson; M B Pepys; S P Wood
Journal:  Structure       Date:  1999-02-15       Impact factor: 5.006

8.  Interference of antimodified C-reactive protein autoantibodies from lupus nephritis in the biofunctions of modified C-reactive protein.

Authors:  Xiao-wei Yang; Ying Tan; Feng Yu; Ming-hui Zhao
Journal:  Hum Immunol       Date:  2011-12-13       Impact factor: 2.850

Review 9.  Origin and physiological roles of inflammation.

Authors:  Ruslan Medzhitov
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

10.  CUTANEOUS REACTIONS IN PNEUMONIA. THE DEVELOPMENT OF ANTIBODIES FOLLOWING THE INTRADERMAL INJECTION OF TYPE-SPECIFIC POLYSACCHARIDE.

Authors:  T Francis; W S Tillett
Journal:  J Exp Med       Date:  1930-09-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.